ORC

Orchid Island Capital, Inc.

$6.80

-7.61%
Apr 16, 2026
Bobby Quantitative Model
Orchid Island Capital is a specialty finance company operating as a REIT in the mortgage sector. It primarily invests in residential mortgage-backed securities guaranteed by U.S. government-sponsored enterprises.

People also watch

Annaly Capital Management

Annaly Capital Management

NLY

Analysis
AGNC Investment Corp. Common Stock

AGNC Investment Corp. Common Stock

AGNC

Analysis
Rithm Capital

Rithm Capital

RITM

Analysis
DX Group

DX Group

DX

Analysis
ARMOUR Residential REIT, Inc.

ARMOUR Residential REIT, Inc.

ARR

Analysis

BobbyInvestment Opinion: Should I buy ORC Today?

Based on a synthesis of the available data, the objective assessment for ORC is a Hold. The stock's deeply discounted valuation (P/E of 5.8, P/B of 0.67) and massive 19.4% dividend yield are powerful attractions for income-focused, risk-tolerant investors. However, these metrics are justified by the company's perilously high leverage, earnings volatility, and sensitivity to interest rates. The limited analyst coverage, which points to a Hold stance, and the stock's weak technical momentum suggest it is not currently positioned for a sustained breakout, making it more suitable for monitoring than initiating a new position.

Sign up to view all

ORC 12-Month Price Forecast

The analysis yields a neutral stance due to opposing powerful forces: irresistible valuation vs. undeniable risk. The high yield anchors the price, but the leverage prevents a bullish outlook. The most likely path is continued range-bound trading, making timing and risk tolerance critical.

Historical Price
Current Price $6.8
Average Target $7
High Target $8.4
Low Target $5.69

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Orchid Island Capital, Inc.'s 12-month outlook, with a consensus price target around $8.84 and implied upside of +30.0% versus the current price.

Average Target

$8.84

2 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

2

covering this stock

Price Range

$5 - $9

Analyst target range

Buy
0 (0%)
Hold
1 (50%)
Sell
1 (50%)

No sufficient analyst coverage available. The provided data includes only two analyst ratings from 2025, both indicating a 'Hold' or 'Market Perform' stance, but no consensus target price or detailed ratings distribution is provided for a current assessment.

Drowning in data?

Find the real signal!

Bulls vs Bears: ORC Investment Factors

ORC presents a classic high-risk, high-potential-reward profile. Its extremely low valuation and high dividend yield are compelling, but these are counterbalanced by severe financial leverage and volatile earnings. The stock appears to be pricing in significant risk, trading near its 52-week low.

Bullish

  • Low Valuation Multiples: P/E of 5.8 and P/B of 0.67 suggest the stock is deeply undervalued.
  • Strong Recent Profitability: Q4 2025 net margin of 78.2% and positive FCF of $120M TTM.
  • High Dividend Yield: Current yield of 19.4% provides significant income for investors.
  • Price Near 52-Week Low: Current price of $6.91 is 17.7% above its 52-week low of $5.69.

Bearish

  • Extremely High Leverage: Debt-to-equity ratio of 7.47 indicates significant financial risk.
  • Volatile Earnings History: Recent quarterly EPS shows high volatility, including negative quarters.
  • Weak Price Momentum: Stock down 7.1% over past month and 9.8% over past year.
  • High Beta and Market Sensitivity: Beta of 1.67 makes stock highly sensitive to market swings.

ORC Technical Analysis

The stock has experienced a volatile downtrend over the past six months, declining 3.9% from a price of $7.19 on October 1, 2025, to $6.91 on March 30, 2026. Short-term performance has been weak, with the stock down 7.12% over the past month and 5.08% over the past three months, though it has shown relative strength compared to the broader market (SPY) over these periods. The current price of $6.91 sits near the lower end of its 52-week range of $5.69 to $8.40, representing approximately 17.7% above the low and 17.7% below the high, indicating a neutral to slightly oversold position.

Beta

1.63

1.63x market volatility

Max Drawdown

-27.9%

Largest decline past year

52-Week Range

$6-$8

Price range past year

Annual Return

+6.4%

Cumulative gain past year

PeriodORC ReturnS&P 500
1m-6.1%+4.6%
3m-18.4%+1.4%
6m-7.2%+5.6%
1y+6.4%+33.5%
ytd-7.7%+2.9%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

ORC Fundamental Analysis

Revenue and profitability have been volatile, with Q4 2025 revenue of $132.2 million showing strong year-over-year growth of 12.35%, and net income of $103.4 million translating to a high net margin of 78.2%. Financial health is characterized by a very high debt-to-equity ratio of 7.47, indicating significant leverage, but the company generated positive free cash flow of $120.4 million over the trailing twelve months. Operational efficiency metrics show a Return on Equity (ROE) of 11.59% and a Return on Assets (ROA) of 1.83%, reflecting moderate efficiency in using its leveraged capital structure.

Quarterly Revenue

$132188000.0B

2025-12

Revenue YoY Growth

+12.34%

YoY Comparison

Gross Margin

+0.29%

Latest Quarter

Free Cash Flow

$120449000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Open an Account, get $2 TSLA now!

Valuation Analysis: Is ORC Overvalued?

Given the positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E is 5.81, and the forward P/E is 5.25, both suggesting the stock is trading at a low earnings multiple. Peer comparison data is not available in the provided inputs, so a relative valuation against industry averages cannot be performed.

PE

5.8x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range -24x~29x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

22.5x

Enterprise Value Multiple

Investment Risk Disclosure

The primary risk for ORC is its capital structure, with a debt-to-equity ratio of 7.47 indicating extreme reliance on leverage to generate returns. This makes the company highly vulnerable to interest rate fluctuations and refinancing risks. A high beta of 1.67 further amplifies its sensitivity to broader market downturns, as seen in its volatile price history and 31.6% max drawdown.

Operational risk stems from the inherent volatility of its mortgage-backed securities portfolio, leading to inconsistent quarterly earnings, including periods of negative EPS. The company's business model is directly tied to the health of the residential mortgage market and Agency (Fannie Mae, Freddie Mac) guarantees. While these provide some credit safety, the portfolio's value and the income it generates are highly sensitive to prepayment speeds and interest rate movements.

Finally, a lack of robust analyst coverage (only two analysts) and institutional interest reduces market transparency and liquidity, potentially leading to exaggerated price swings. The high short interest ratio of 1.82 also indicates a significant portion of the market holds a bearish view, which can create downward pressure.

FAQ

The paramount risk is financial leverage, with a debt-to-equity ratio of 7.47, making the company vulnerable to rising interest rates and refinancing risk. Second, its earnings from mortgage-backed securities are highly volatile, as seen in quarterly EPS swings. Third, the stock has high market sensitivity (Beta of 1.67) and has experienced a max drawdown of -31.6%. Finally, the sustainability of its high dividend is contingent on stable portfolio income.

The 12-month outlook is mixed with a neutral base case. The base case (50% probability) sees the stock trading between $6.50 and $7.50, range-bound by its high yield and high risk. A bull case (25%) could see it rally towards its 52-week high of $8.40 if interest rates fall. A bear case (25%) could see it retest its 52-week low of $5.69 if financial conditions worsen. The consensus lacks a clear directional catalyst.

Based on traditional metrics, ORC appears deeply undervalued. It trades at a trailing P/E of 5.8, a forward P/E of 5.25, and a Price-to-Book ratio of just 0.67. However, this low valuation reflects the market's pricing of substantial risks, primarily its extreme leverage (D/E of 7.47) and earnings volatility. Therefore, it is arguably fairly valued given its risk profile, not a clear-cut undervaluation.

ORC is a speculative buy only for high-risk-tolerance investors seeking extreme income. Its 19.4% dividend yield and low P/E ratio of 5.8 are compelling, but these are counterbalanced by a dangerously high debt-to-equity ratio of 7.47 and volatile earnings. For most investors, the significant financial leverage and interest rate sensitivity make it a Hold rather than a strong Buy.

ORC is not ideal for a traditional long-term growth portfolio due to its leveraged, volatile nature. It may be considered by long-term investors solely for its high income, but they must accept significant principal risk. It is also a challenging short-term trade due to its volatility and sensitivity to daily interest rate news. It is best suited for tactical, income-focused investors with a medium-term horizon who can actively monitor interest rate risks.